Vascular-Targeted Photodynamic Therapy Treats Prostate Cancer
December 20, 2016
In a recent study found in The Lancet Oncology, more than 400 men with localized prostate cancer were treated with vascular-targeted photodynamic therapy (VTP), which was found to kill prostate cancer cells without damaging healthy surrounding tissue and with a reduced need for radical therapy.
At the end of the 2-year follow-up after the VTP treatment was conducted, researchers found the 49% of patients had entered complete remission.
"This is truly a huge leap forward for prostate cancer treatment, which has previously lagged decades behind other solid cancers such as breast cancer. In 1975, almost everyone with breast cancer was given a radical mastectomy, but since then treatments have steady improved and we now rarely need to remove the whole breast. In prostate cancer we are still commonly removing or irradiating the whole prostate, so the success of this new tissue-preserving treatment is welcome news indeed," said lead investigator Professor Mark Emberton, dean of medical sciences and a consultant urologist at University College London in the United Kingdom.
For more on this story, go to: http://www.medicalnewstoday.com/articles/314830.php